Circulation, Vol 72, 1148-1154, Copyright © 1985 by American Heart Association
JM Criley and RJ Siegel
HCM is a disorder associated with significant morbidity and mortality and a
propensity to cause sudden, often unexpected death. The similarity to the
symptom complex of aortic stenosis and the presence of a pressure gradient
justified the initial assumption that obstruction was of prime importance
in HCM and that relief of obstruction was the focal point of rational
therapy. However, it is our belief that the dogma of obstruction has
impeded progress in and obscured the understanding of HCM and
interpretation of its manifestations. The purpose of this article is to
call attention to significant discrepancies in the obstructive concept that
have been reinforced as new techniques emerged that have allowed further
study of the disease. Since neither the presence of a gradient nor SAM can
be justifiably equated with the presence of an obstruction, it is proposed
that the appellation "obstruction" be reserved for those cases in which the
rate of outflow or the rate or degree of ventricular emptying are
demonstrably impeded, as in aortic stenosis. Therapy with beta-
adrenergic-receptor and calcium channel-blocking agents have shown promise
for alleviating symptoms and possibly prolonging life without
systematically or predictably affecting the pressure gradient, probably
because of their beneficial effects on ventricular relaxation and diastolic
filling. Antiarrhythmic therapy has been effective in reducing mortality.
Ideally, prevention or regression of the pathologic hypertrophy should be
the major focus of future therapeutic interventions in hypertrophic
cardiomyopathy.
ARTICLES
Has 'obstruction' hindered our understanding of hypertrophic cardiomyopathy?
This article has been cited by other articles:
![]() |
B. J. Maron, M. S. Maron, E. D. Wigle, and E. Braunwald The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., July 14, 2009; 54(3): 191 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
S R Ommen, P M Shah, and A J Tajik Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future Heart, October 1, 2008; 94(10): 1276 - 1281. [Full Text] [PDF] |
||||
![]() |
R. A. Nishimura and S. R. Ommen Hypertrophic Cardiomyopathy: The Search for Obstruction Circulation, November 21, 2006; 114(21): 2200 - 2202. [Full Text] [PDF] |
||||
![]() |
M. S. Maron, I. Olivotto, S. Betocchi, S. A. Casey, J. R. Lesser, M. A. Losi, F. Cecchi, and B. J. Maron Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy N. Engl. J. Med., January 23, 2003; 348(4): 295 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.J. Paulus Natriuretic peptides to probe haemodynamic overload in hypertrophic cardiomyopathy Eur. Heart J., August 1, 2001; 22(15): 1249 - 1251. [Abstract] [PDF] |
||||
![]() |
S. R. Ommen, R. A. Nishimura, R. W. Squires, H. V. Schaff, G. K. Danielson, and A. J. Tajik Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points J. Am. Coll. Cardiol., July 1, 1999; 34(1): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kizilbash, S. K. Heinle, and P. A. Grayburn Spontaneous Variability of Left Ventricular Outflow Tract Gradient in Hypertrophic Obstructive Cardiomyopathy Circulation, February 10, 1998; 97(5): 461 - 466. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1985 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |